Lincoln Park Capital Fund LLC 13D and 13G filings for Cellectar Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:29 pm Purchase |
2023-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Lincoln Park Capital Fund LLC | 1,307,049 9.676% |
369,461 (+39.41%) |
Filing |
| 2022-10-25 06:01 am Purchase |
2022-10-21 | 13G | Cellectar Biosciences, Inc. CLRB |
Lincoln Park Capital Fund LLC | 937,588 9.990% |
706,220 (+305.24%) |
Filing |
| 2020-07-13 2:38 pm Purchase |
2020-07-11 | 13G | Cellectar Biosciences, Inc. CLRB |
Lincoln Park Capital Fund LLC | 231,368 8.920% |
231,368 (New Position) |
Filing |